JD

John De Koning

Partner at EQT Life Sciences

Amsterdam, North Holland

Overview 

John de Koning is a Partner at EQT Life Sciences (formerly LSP) in Amsterdam, North Holland. With a background in oncology and biotechnology, he has served on the boards of companies such as Visus Therapeutics, VarmX, and eTheRNA Immunotherapies, and has made strategic investments in companies like Tubulis and Merus.

Work Experience 

TG

Tubulis GmbH

  • Board Observer

    2024 - Current

a

atbtherapeutics

  • Board Member

    2024

EL

EQT Life Sciences

  • Partner

    2006

    EQT Life Sciences (formerly LSP), is one of Europe’s largest and most experienced healthcare investment firms, targeting innovative life sciences and health care companies.

TT

Tenpoint Therapeutics, Ltd.

  • Board Member

    2021

x

xilis

  • Board Observer

    2021

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Raised $92,000,000.00 from FPV Ventures, EQT, Two Sigma Ventures, Mubadala Capital Ventures, Google Ventures, Alix Ventures, Alexandria Venture Investments, Felicis, Duke Angel Network and Catalio Capital Management.

xilis.net
V

VarmX

  • Board Member

    2020

XT

XyloCor Therapeutics, Inc.

  • Board Observer

    2018

XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.

Raised $39,600,000.00 from Longwood Fund, EQT Life Sciences, Sofinnova Investments, Lumira Ventures, Fountain Healthcare Partners, EQT Life Sciences and Sofinnova Investments.

xylocor.com
eI

eTheRNA Immunotherapies

  • Board Member

    2016

O

ONWARD

  • Board Member

    2016

Aelin Therapeutics

  • Board Member

    2017 - 2023

Education 

Investments 

Tubulis

Series B

Total funding: $210M

VarmX

Series B

Total funding: $83M

etherna immunotherapies

Series A

Total funding: $66M

Visus Therapeutics

Debt Financing

Total funding: $61M

Articles About John

Relevant Websites